Zoetis Inc. A Stock
€133.40
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Zoetis
sharewise wants to provide you with the best news and tools for Zoetis, so we directly link to the best financial data sources.
Financials
News
Zoetis Stock: Weak 2025 Outlook Triggers Sharp Decline
Zoetis, the leading veterinary pharmaceutical company, demonstrated robust performance in the fourth quarter with revenue climbing 5 percent to $2.3 billion. The adjusted earnings per share reached
2 Recession-Proof Stocks to Buy and Hold
President Trump's trade policies are sparking concerns about a potential recession. Though it's hard to predict an upcoming economic downturn, it's never a bad idea for investors to buy shares of
Beat the S&P 500 With This Cash-Gushing Dividend Stock
You don't need to uncover the next big artificial intelligence stock to outperform the broader stock market. Sometimes, consistent and profitable growth is all you need to achieve outsize investment
1 Superstar Dividend Growth Stock to Buy if the Market Crashes
The stock market has entered a new period of increased uncertainty and volatility following the Trump Administration's desire to reshape America's trade policies. While the market hasn't crashed
A Once-in-a-Decade Opportunity: 3 Magnificent Stocks Down Between 40% and 73% to Buy Right Now
The S&P 500 has dropped 10% or more nine times since 2010, not including the current sell-off. However, the index has delivered an average return of 18% in the year following the start date of these
This Magnificent Dividend Stock Has Increased Its Payouts by 500% in 10 Years
There are many dividend stocks on equity markets, but not all are attractive to income investors. Those that go beyond paying a quarterly payout but also consistently raise their dividends -- all
Zoetis' Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.
Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now
It is a beautiful thing when you find a feel-good stock that offers market-beating potential. A perfect example of this combination today is animal healthcare specialist Zoetis (NYSE: ZTS).
Whether
Why Zoetis Stock Took Another Tumble Today
One day after unveiling quarterly results that disappointed the market and engendered a stock sell-off, Zoetis (NYSE: ZTS) shares again tumbled. As of late-session trading on Friday, they were down
Why Zoetis Stock Was Falling Today
Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up short in its fourth quarter.
Though it topped estimates on the top and
Zoetis (ZTS) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Zoetis (NYSE: ZTS)Q4 2024 Earnings CallFeb 13, 2025, 8:30 a.m. ET
Operator
Source Fool.com
Zoetis Earnings Top Analysts' Forecasts
Zoetis (NYSE:ZTS), the leader in animal health solutions, released its fourth quarter results for 2024 on Feb. 13. The company reported an adjusted earnings per share (EPS) of $1.40, which exceeded